Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy.

Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy.

Item
http://www.wikidata.org/entity/Q34580727
Molecular and cell-based therapies for muscle degenerations: a road under constructionSMRT compounds correct nonsense mutations in primary immunodeficiency and other genetic modelsCystic fibrosis transmembrane conductance regulator modulators in cystic fibrosis: current perspectivesClinical and molecular characterization of a cohort of patients with novel nucleotide alterations of the Dystrophin gene detected by direct sequencingCFTR Modulators for the Treatment of Cystic Fibrosis.Targets for cystic fibrosis therapy: proteomic analysis and correction of mutant cystic fibrosis transmembrane conductance regulatorAminoglycoside-induced mutation suppression (stop codon readthrough) as a therapeutic strategy for Duchenne muscular dystrophyA translational approach for limb vascular delivery of the micro-dystrophin gene without high volume or high pressure for treatment of Duchenne muscular dystrophyMolecular therapeutic strategies targeting Duchenne muscular dystrophyNovel compounds for the treatment of Duchenne muscular dystrophy: emerging therapeutic agentsMicroarray-based mutation detection in the dystrophin gene.Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease.Mesenchymal stem cells: emerging therapy for Duchenne muscular dystrophyRescue of non-sense mutated p53 tumor suppressor gene by aminoglycosides.
P2860

Drug evaluation: PTC-124--a potential treatment of cystic fibrosis and Duchenne muscular dystrophy.

Item
http://www.wikidata.org/entity/Q34580727
description
2006 nî lūn-bûn
@nan
2006 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@ast
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@en
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@nl
type
label
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@ast
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@en
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@nl
prefLabel
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@ast
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@en
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@nl
P1433
P1476
P2093
P304
P31
P433
P478
P577
P698
P921
P1433
P1476
Drug evaluation: PTC-124--a po ...... d Duchenne muscular dystrophy.
@en
P2093
P304
P31
P433
P478
P577
P698
P921